By Sahil Pandey and Siddhi Mahatole Feb 23 (Reuters) - Gossamer Bio's experimental treatment failed to significantly improve exercise capacity in patients with a rare lung condition in a late-stage ...

Feb 23 (Reuters) - Gossamer Bio said on Monday its experimental drug for patients with a type of lung condition missed the main goal of a late-stage study, sending the drug developer's shares down 80% ...

Did you know that something as delicious as chocolate or as common as an apple could be working wonders for your blood ...

Marching and wall sits are kinds of workouts that can offer specific health benefits. These 5-minute workouts can improve ...

You know that pitchers run the risk of blowing out an elbow ligament. But who would have thought they could lose a rib?

Modulating miR-21 signaling may work to reduce heart damage in people with pulmonary hypertension (PH), a preclinical study suggests.

Gossamer Bio, Inc. a biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension ...

Those of us who watch the Olympics as bystanders tend to smugly judge athletes for succumbing to pressure without ...